tradmap

STE Financials Steris

10 years of revenue, profit, cash flow and balance-sheet history through FY2026, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 13.8% per year over the past 5 years.
  • Net income has grown faster than revenue (14.5% vs 13.8% per year).
  • Operating margin has been roughly flat, at 18.6% in the latest year.
  • Free cash flow has grown 16.6% per year over the past 5 years.

Financial health

  • Total debt ($1.9B) exceeds cash ($440M); net debt is $1.5B.
  • Total debt has grown slower than revenue (3.2% vs 13.8% per year).
  • Operating income covered interest expense 18× in the latest year.
  • Total debt is 1.2× EBITDA.

Shareholder returns

  • Dividends have been paid for 10 consecutive years, consuming 30.9% of earnings and 24.9% of free cash flow.
  • The dividend has grown 12.6% per year over the past 5 years.
Revenue & net income
$0 $3B $6B 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
RevenueNet income
Margins (gross / operating / net)
0% 22% 45% 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
GrossOperatingNet
Free cash flow (CFO − capex)
$0 $486M $972M 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Free cash flow
Cash vs total debt
$0 $2B $3B 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
CashTotal debt
Cash flow: operating / investing / financing
-$2B -$116M $1B $0 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2026 $5.9B $782M 44.2% 18.6% $972M $1.9B $440M
2025 $5.5B $615M 44.0% 15.9% $778M $2.0B $172M
2024 $5.1B $378M 43.2% 16.3% $613M $3.2B $207M
2023 $4.5B $107M 43.7% 17.4% $395M $3.1B $208M
2022 $4.2B $244M 44.6% 11.3% $397M $3.1B $348M
2021 $3.1B $397M 43.2% 17.6% $450M $1.7B $221M
2020 $3.0B $408M 43.6% 17.7% $376M $1.2B $320M
2019 $2.8B $304M 42.2% 14.8% $350M $1.2B $221M
2018 $2.6B $291M 41.7% 15.3% $292M $1.3B
2017 $2.6B $110M 39.3% 8.7% $251M

Valuation over time

How the market has priced STE against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 106.2 212.5 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/E
Price / sales (P/S)
0.0 2.5 5.0 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S
Dividend yield (%)
0.0 0.6 1.2 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
Dividend yield %

Frequently asked questions

Is STE growing its revenue and profit?

Over the past 5 years, Steris's revenue has grown 13.8% per year, and net income grown 14.5% per year. These are computed facts, not advice.

How much debt does STE have?

As of FY2026, Steris reported $1.9B of total debt against $440M of cash; operating income covered interest expense 18×.

What is STE's profit margin?

In FY2026, gross margin was 44.2%, operating margin 18.6%, and net margin 13.2%.

What is STE's P/E ratio?

As of Jun '26, Steris traded at a price-to-earnings ratio of about 26.3× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.